Annual Total Expenses
$67.64 M
-$8.27 M-10.90%
December 31, 2023
Summary
- As of February 7, 2025, NXTC annual total expenses is $67.64 million, with the most recent change of -$8.27 million (-10.90%) on December 31, 2023.
- During the last 3 years, NXTC annual total expenses has risen by +$4.03 million (+6.34%).
- NXTC annual total expenses is now -10.90% below its all-time high of $75.91 million, reached on December 31, 2022.
Performance
NXTC Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$12.49 M
-$4.00 M-24.25%
September 30, 2024
Summary
- As of February 7, 2025, NXTC quarterly total expenses is $12.49 million, with the most recent change of -$4.00 million (-24.25%) on September 30, 2024.
- Over the past year, NXTC quarterly total expenses has dropped by -$3.29 million (-20.87%).
- NXTC quarterly total expenses is now -39.84% below its all-time high of $20.77 million, reached on March 31, 2022.
Performance
NXTC Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
NXTC Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.9% | -20.9% |
| 3 y3 years | +6.3% | -32.5% |
| 5 y5 years | +191.6% | +10.7% |
NXTC Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.9% | at low | -39.8% | at low |
| 5 y | 5-year | -10.9% | +54.3% | -39.8% | at low |
| alltime | all time | -10.9% | +335.0% | -39.8% | +149.4% |
NextCure Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.49 M(-24.2%) |
| Jun 2024 | - | $16.49 M(+4.6%) |
| Mar 2024 | - | $15.76 M(-0.2%) |
| Dec 2023 | $67.64 M(-10.9%) | $15.79 M(+1.1%) |
| Sep 2023 | - | $15.62 M(-18.5%) |
| Jun 2023 | - | $19.16 M(+12.2%) |
| Mar 2023 | - | $17.07 M(-3.9%) |
| Dec 2022 | $75.91 M(+7.3%) | $17.77 M(-7.6%) |
| Sep 2022 | - | $19.24 M(+6.1%) |
| Jun 2022 | - | $18.13 M(-12.7%) |
| Mar 2022 | - | $20.77 M(+21.7%) |
| Dec 2021 | $70.77 M | $17.07 M(-7.8%) |
| Sep 2021 | - | $18.51 M(+3.1%) |
| Jun 2021 | - | $17.95 M(+4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $17.23 M(+6.1%) |
| Dec 2020 | $63.60 M(+45.1%) | $16.24 M(-6.7%) |
| Sep 2020 | - | $17.40 M(+10.1%) |
| Jun 2020 | - | $15.80 M(+11.5%) |
| Mar 2020 | - | $14.17 M(+1.1%) |
| Dec 2019 | $43.83 M(+89.0%) | $14.02 M(+24.2%) |
| Sep 2019 | - | $11.29 M(+9.0%) |
| Jun 2019 | - | $10.36 M(+26.7%) |
| Mar 2019 | - | $8.17 M(+15.6%) |
| Dec 2018 | $23.20 M(+49.2%) | $7.07 M(+21.4%) |
| Sep 2018 | - | $5.82 M(+9.8%) |
| Jun 2018 | - | $5.30 M(+5.8%) |
| Mar 2018 | - | $5.01 M |
| Dec 2017 | $15.55 M | - |
FAQ
- What is NextCure annual total expenses?
- What is the all time high annual total expenses for NextCure?
- What is NextCure annual total expenses year-on-year change?
- What is NextCure quarterly total expenses?
- What is the all time high quarterly total expenses for NextCure?
- What is NextCure quarterly total expenses year-on-year change?
What is NextCure annual total expenses?
The current annual total expenses of NXTC is $67.64 M
What is the all time high annual total expenses for NextCure?
NextCure all-time high annual total expenses is $75.91 M
What is NextCure annual total expenses year-on-year change?
Over the past year, NXTC annual total expenses has changed by -$8.27 M (-10.90%)
What is NextCure quarterly total expenses?
The current quarterly total expenses of NXTC is $12.49 M
What is the all time high quarterly total expenses for NextCure?
NextCure all-time high quarterly total expenses is $20.77 M
What is NextCure quarterly total expenses year-on-year change?
Over the past year, NXTC quarterly total expenses has changed by -$3.29 M (-20.87%)